Put Options

12 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$9.17 - $19.29 $1.07 Million - $2.25 Million
116,400 New
116,400 $1.29 Million
Q4 2022

Feb 14, 2023

SELL
$11.61 - $16.11 $267,030 - $370,530
-23,000 Reduced 69.7%
10,000 $123,000
Q3 2022

Nov 14, 2022

BUY
$12.21 - $19.7 $402,930 - $650,100
33,000 New
33,000 $461,000
Q1 2021

May 14, 2021

SELL
$19.33 - $37.75 $564,436 - $1.1 Million
-29,200 Reduced 13.73%
183,400 $4.23 Million
Q4 2020

Feb 16, 2021

SELL
$24.48 - $42.47 $5.2 Million - $9.02 Million
-212,300 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$24.48 - $42.47 $5.2 Million - $9.03 Million
212,600 New
212,600 $5.25 Million
Q3 2020

Nov 13, 2020

BUY
$39.09 - $53.44 $50,817 - $69,472
1,300 Added 0.62%
212,300 $8.8 Million
Q2 2020

Aug 14, 2020

BUY
$46.7 - $92.04 $2.26 Million - $4.45 Million
48,400 Added 29.77%
211,000 $10.1 Million
Q1 2020

May 15, 2020

BUY
$48.35 - $118.68 $7.38 Million - $18.1 Million
152,600 Added 1526.0%
162,600 $10.2 Million
Q2 2019

Aug 14, 2019

BUY
$77.77 - $120.68 $466,620 - $724,080
6,000 Added 150.0%
10,000 $796,000
Q3 2018

Nov 14, 2018

SELL
$88.49 - $127.55 $530,940 - $765,300
-6,000 Reduced 60.0%
4,000 $505,000
Q3 2017

Nov 14, 2017

BUY
$57.01 - $118.75 $570,100 - $1.19 Million
10,000
10,000 $580,000

Others Institutions Holding ICPT

About INTERCEPT PHARMACEUTICALS, INC.


  • Ticker ICPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,127,400
  • Description
  • Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...
More about ICPT
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.